Key Personnel
Leadership team
Tony Lim
Clinical Director, MBBS, FRCPath, FRCPA
Senior Consultant, Dept of Pathology, SGH
Deepa SUBRAMANIAN
Chief Operating Officer, PhD
Genome Institute of Singapore
Su Yan
Chief Technical Officer, PhD
Genome Institute of Singapore
Disease Champions
Daniel Tan
Lung Cancer, MBBS, MRCP(UK), FAMS
Senior Consultant, NCCS
Iain Tan
Gastrointestinal Cancer, MBBS, MRCP(UK), PhD
Senior Consultant, NCCS
Founding Member
Patrick Tan
Executive Director, ED, PhD
Genome Institute of Singapore
Alexander Lezhava
Alexander Lezhava
Program Director, PhD
Senior Investigator, Genome Institute of Singapore
RESEARCH
Selected Publications
Suzuki Y, Ng SB, Chua C, Leow WQ, Chng J, Liu SY, Ramnarayanan K, Gan A, Ho DL, Ten R, Su Y, Lezhava A, Lai JH, Koh D, Lim KH, Tan P, Rozen SG, Tan IB "Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer." Mol Oncol 2017 Feb ; 11(2) : 124-139 Abstract
Wang SR, Malik S, Tan IB, Chan YS, Hoi Q, Ow JL, He CZ, Ching CE, Poh DY, Seah HM, Cheung KH, Perumal D, Devasia AG, Pan L, Ang S, Lee SE, Ten R, Chua C, Tan DS, Qu JZ, Bylstra YM, Lim L, Lezhava A, Ng PC, Wong CW, Lim T, Tan P "Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer." J Mol Diagn 2016 May ; 18(3) : 416-24 Abstract
Yoshida K, Takano J, Ishizu Y, Lezhava A, Ieiri I, Maeda K, Hayashizaki Y, Sugiyama Y "Direct and rapid genotyping of SLCO1B1 388A>G and 521T>C in human blood specimens using the SmartAmp-2 method." AAPS J 2013 Apr ; 15(2) : 618-22 Epub 2013 Mar 8 Abstract
Kawai Y, Kimura Y, Lezhava A, Kanamori H, Usui K, Hanami T, Soma T, Morlighem JÉ, Saga S, Ishizu Y, Aoki S, Endo R, Oguchi-Katayama A, Kogo Y, Mitani Y, Ishidao T, Kawakami C, Kurata H, Furuya Y, Saito T, Okazaki N, Chikahira M, Hayashi E, Tsuruoka S, Toguchi T, Saito Y, Ban T, Izumi S, Uryu H, Kudo K, Sakai-Tagawa Y, Kawaoka Y, Hirai A, Hayashizaki Y, Ishikawa T "One-step detection of the 2009 pandemic influenza A(H1N1) virus by the RT-SmartAmp assay and its clinical validation." PLoS One 2012 ; 7(1) : e30236 Epub 2012 Jan 25 Abstract
Kimura Y, de Hoon MJ, Aoki S, Ishizu Y, Kawai Y, Kogo Y, Daub CO, Lezhava A, Arner E, Hayashizaki Y "Optimization of turn-back primers in isothermal amplification." Nucleic Acids Res 2011 May ; 39(9) : e59 Epub 2011 Feb 9 Abstract
Lezhava A, Ishidao T, Ishizu Y, Naito K, Hanami T, Katayama A, Kogo Y, Soma T, Ikeda S, Murakami K, Nogawa C, Itoh M, Mitani Y, Harbers M, Okamoto A, Hayashizaki Y "Exciton Primer-mediated SNP detection in SmartAmp2 reactions." Hum Mutat 2010 Feb ; 31(2) : 208-17 Abstract
Toyoda Y, Sakurai A, Mitani Y, Nakashima M, Yoshiura K, Nakagawa H, Sakai Y, Ota I, Lezhava A, Hayashizaki Y, Niikawa N, Ishikawa T "Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type?" FASEB J 2009 Jun ; 23(6) : 2001-13 Epub 2009 Apr 21 Abstract
Aomori T, Yamamoto K, Oguchi-Katayama A, Kawai Y, Ishidao T, Mitani Y, Kogo Y, Lezhava A, Fujita Y, Obayashi K, Nakamura K, Kohnke H, Wadelius M, Ekström L, Skogastierna C, Rane A, Kurabayashi M, Murakami M, Cizdziel PE, Hayashizaki Y, Horiuchi R "Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2." Clin Chem 2009 Apr ; 55(4) : 804-12 Epub 2009 Jan 30 Abstract
Hoshi K, Takakura H, Mitani Y, Tatsumi K, Momiyama N, Ichikawa Y, Togo S, Miyagi T, Kawai Y, Kogo Y, Kikuchi T, Kato C, Arakawa T, Uno S, Cizdziel PE, Lezhava A, Ogawa N, Hayashizaki Y, Shimada H "Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification Process." Clin Cancer Res 2007 Sep 1 ; 13(17) : 4974-83 Abstract
Mitani Y, Lezhava A, Kawai Y, Kikuchi T, Oguchi-Katayama A, Kogo Y, Itoh M, Miyagi T, Takakura H, Hoshi K, Kato C, Arakawa T, Shibata K, Fukui K, Masui R, Kuramitsu S, Kiyotani K, Chalk A, Tsunekawa K, Murakami M, Kamataki T, Oka T, Shimada H, Cizdziel PE, Hayashizaki Y "Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology." Nat Methods 2007 Mar ; 4(3) : 257-62 Epub 2007 Feb 18 Abstract
KEY ACHIEVEMENT
2010-2012 Visiting Professor of Clinical Research, Yokohama City University Graduate School of Medicine, Japan
2009 Letter of Appreciation from President of RIKEN
2007 Suzuken Memorial Foundation award, Japan
2008 Visiting Professor of Tbilisi Central University Clinic, Georgia
Sarah Ng
Sarah Ng
Chief Information Officer, PhD
Platform Leader, Genome Institute of Singapore
RESEARCH FOCUS
EDUCATION
2012 University of Washington, Ph.D. in Genome Sciences
2006 University of Wisconsin-Madison, B.S. in Molecular Biology
PROFESSIONAL APPOINTMENTS
Nov 2012 - Oct 2016 Research Fellow, Microfluidics Systems Biology, IMCB, Singapore
HONORS AND AWARDS
2003 National Science Scholarship, A*STAR, Singapore
COMPLETE PUBLICATION LIST
Ho Ying Swan
Ho Ying Swan
Metabolomics, PhD
Research Scientist, Bioprocessing Technology Institute
Research Focus/Interests
- Metabolomics/metabolite profiling of mammalian cell lines to further understanding of intracellular metabolic processes and their impact on recombinant protein production and quality
- Application of metabolite profiling to identify candidate disease markers and to study aberrant metabolism under disease conditions
Wendy Soon
Wendy Soon
Chief Sequencing Officer, PhD
Platform Leader, Genome Institute of Singapore
RESEARCH FOCUS
EDUCATION
2013 Innovation and Entrepreneurship, Stanford Graduate School of Business
2011 PhD, Cancer Genomics and Cancer Biology, National University of Singapore
2007 BSc, Life Sciences (concentration in Biomedical Sciences), National University of Singapore
PROFESSIONAL APPOINTMENTS
2013-present Manager, Next Generation Sequencing Platform, Genome Institute of Singapore
2011-2013 Postdoctoral Fellow, Snyder Lab, Centre for Genomics and Personalized Medicine, Stanford University
2011-2011 Research Fellow, Genome Institute of Singapore
HONORS AND AWARDS
2011-2013 A*STAR Overseas Postdoctoral Fellowship
2007-2011 A*STAR Graduate Scholarship
2006-2007 A*STAR Pre-Graduate Scholarship
2003-2004 Dean's List, National University of Singapore
2000 Raffles Top Scholar Award
2000 National Youth Achievement Award
2000 Singapore Mathematical Olympiad, Bronze medalist
COMPLETE PUBLICATION LIST
Inaki k, Menghi F, Woo XY, Wagner JP, Jacques PE, Lee YF, Shreckengast PT, Soon WW, Malhotra A, Teo ASM, Hillmer AM, Khng AJ, Ruan X, Ong SH, Bertrand D, Nagarajan N, Karuturi RKM, Miranda AH, Liu ET. (2014) Systems consequences of amplicon formation in human breast cancer. Genome Research. 24, 1559-1571.
Soon WW, Karaturi KM, Irwanto A, Yao F, Ruan Y and Liu ET. Combinatorial Genomic Screen reveals strong tumor suppressor gene SEMA6D, an apoptotic inducer associated with good patient survival in breast cancer. (Submitted)
Soon WW, Hariharan M and Snyder M. High throughput sequencing for biology and medicine. (2013) Molecular Systems Biology 9, 640.
Soon WW, Miller LD, Dalmasso C, Desai KV and Liu ET. Combined genomic and phenotype screening reveals the secretory factor SPINK1 as a invasion and survival factor associated with patient prognosis in breast cancer. (2011) EMBO Molecular Medicine 3(8), 451-464.
Roger Foo
Roger Foo
Rare Disease, MBBS, MRCP(UK), PhD
Group Leader, Human Genetics Laboratory, GIS
RESEARCH FOCUS
Laboratory of Cardiac Epigenome, Molecular Epigenetics and Stress-gene Response.
Heart failure is a major cause of mortality and morbidity in the world today. Easily rivalling the severity of some forms of cancer, life expectancy for patients with heart failure at 5 years can be as poor as <50%. Novel targets are urgently needed for the heart failure drug discovery pipeline. Moreover, current therapy slows disease progression, but does not reverse the course of disease. Although heart failure can be caused by different originating causes including hypertension, diabetes, myocardial infarction and genetic mutations, it is nonetheless characterised by convergent processes such as fibrosis, angiogenesis and cell death. Similarly a consistent pattern of gene expression constitutes the myocardial genomic stress-response in the progression of heart failure. A hallmark for this myocardial genomic stress-response includes fetal gene reprogramming, upregulation of extracellular matrix genes and others.
The epigenome refers to “marks” on the genome including histone modifications and DNA methylation. Our group published the first evidence that differential DNA methylation exists in end-stage human cardiomyopathic hearts and correlates to changes in specific gene expression. By high-throughput sequencing, we have also published the first glimpse of genome-wide DNA methylation landscapes of the failing human heart. A major effort in the lab now is to deep dive and to establish the role of the cardiac epigenome and chromatin reorganization in heart failure onset and progression. To achieve this, we employ a host of genomic and molecular tools, with tractable in vitro and in vivo experimental models as well as human explant tissue to study the myocardial genomic and epigenomic stress response. Epigenetic tools represent a real potential for finding refreshing molecular therapeutic approaches that work to reverse the course of disease, rather than just slowing down its progression.
The recent large BMRC SPF Cardiovascular Research grant award consists of a Genetics/Epigenetics theme which our group leads. This has the ambitious aim of mapping out functional elements in the cardiac genome and epigenome, opening up a new and important area of cardiovascular research. We hope that all together our work will eventually lead to the identification of novel targets for future heart failure therapy.
In a separate translational programme, our lab was also responsible for establishing Singapore’s first Inherited Cardiac Conditions clinic based at the National University Heart Centre. This clinic makes use of high-throughput sequencing-based genetic test panels developed at the Genome Institute of Singapore.
EDUCATION
1992 MBBS, National University of Singapore
1997 MRCP, Royal College of Physicians UK
2000 MD University of Leicester UK
2003 CCT, Completetion of Specialist Training, Cambridge University Hospitals NHS Foundation Trust, UK
PROFESSIONAL APPOINTMENTS
2012-Associate Professor, Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore
2012- Senior Consultant, National University Heart Centre, National University Healthcare System, Singapore
2012- Adjunct Senior Investigator, Genome Institute of Singapore
2012 Visiting Fellow, Department of Medicine, University of Cambridge, UK
2007-2012 British Heart Foundation Intermediate Fellow, Division of Cardiovascular Medicine, University of Cambridge, UK
2007-2012 Consultant Physician, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
2003-2007 Wellcome Trust Advanced Fellow, Albert Einstein College of Medicine, NY
1999-2003 Specialist Registrar, Division of Cardiovascular Medicine and Clinical Pharmacology Unit, University of Cambridge
1997-1999 Junior Research Fellow, University of Leicester, UK
1996-1997 Senior House Officer, Department of Medicine, Kings College Hospital, London
HONOR AND AWARDS
2012 Fellow, American Heart Association
2012 Associate Member, EpiGeneSys EU Epigenetics systems biology programme
2006 Finalist, Katz Basic Science Research Prize, American Heart Association
2003 Philip White Award, British Cardiac Society
2001 Medical Research Society London Abstract Prize
1999 Grimshaw-Parkinson Trust Award, University of Cambridge, UK
COMPLETE PUBLICATION LIST
Reijnders MRF, Janowski R, Alvi M, Self JE, van Essen TJ, Vreeburg M, Rouhl RPW, Stevens SJC, Stegmann APA, Schieving J, Pfundt R, van Dijk K, Smeets E, Stumpel CTRM, Bok LA, Cobben JM, Engelen M, Mansour S, Whiteford M, Chandler KE, Douzgou S, Cooper NS, Tan EC, Foo R, Lai AHM, Rankin J, Green A, Lönnqvist T, Isohanni P, Williams S, Ruhoy I, Carvalho KS, Dowling JJ, Lev DL, Sterbova K, Lassuthova P, Neupauerová J, Waugh JL, Keros S, Clayton-Smith J, Smithson SF, Brunner HG, van Hoeckel C, Anderson M, Clowes VE, Siu VM, Ddd Study T, Selber P, Leventer RJ, Nellaker C, Niessing D, Hunt D, Baralle D "PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature." J Med Genet 2018 Feb ; 55(2) : 104-113
Abstract
Kam S, Bylstra Y, Forrest L, Macciocca I, Foo R "Experience of Asian males communicating cardiac genetic risk within the family." J Community Genet 2018 Jul ; 9(3) : 293-303
Abstract
Zhao RR, Ackers-Johnson M, Stenzig J, Chen C, Ding T, Zhou Y, Wang P, Ng SL, Li PY, Teo G, Rudd PM, Fawcett JW, Foo RSY "Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological Remodeling." Circulation 2018 Jun 05 ; 137(23) : 2497-2513
Abstract
Stenzig J, Schneeberger Y, Löser A, Peters BS, Schaefer A, Zhao RR, Ng SL, Höppner G, Geertz B, Hirt MN, Tan W, Wong E, Reichenspurner H, Foo RS, Eschenhagen T "Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats." J Mol Cell Cardiol 2018 Jul ; 120 : 53-63
Abstract
Bylstra Y, Kuan JL, Lim WK, Bhalshankar JD, Teo JX, Davila S, Teh BT, Rozen S, Tan EC, Liew WKM, Yeo KK, Tan P, Saw SM, Cheng CY, Cook S, Foo R, Jamuar SS "Population genomics in South East Asia captures unexpectedly high carrier frequency for treatable inherited disorders." Genet Med 2018 Jul 02
Abstract
Tan WL, Lim BT, Anene-Nzelu CG, Ackers-Johnson M, Dashi A, See K, Tiang Z, Lee DP, Chua WW, Luu TD, Li PY, Richards AM, Foo RS "A landscape of circular RNA expression in the human heart." Cardiovasc Res 2017 Mar 01 ; 113(3) : 298-309
Abstract
Zhai W, Lim TK, Zhang T, Phang ST, Tiang Z, Guan P, Ng MH, Lim JQ, Yao F, Li Z, Ng PY, Yan J, Goh BK, Chung AY, Choo SP, Khor CC, Soon WW, Sung KW, Foo RS, Chow PK "The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma." Nat Commun 2017 Feb 27 ; 8 : 4565
Abstract
See K, Tan WLW, Lim EH, Tiang Z, Lee LT, Li PYQ, Luu TDA, Ackers-Johnson M, Foo RS "Single cardiomyocyte nuclear transcriptomes reveal a lincRNA-regulated de-differentiation and cell cycle stress-response in vivo." Nat Commun 2017 08 09 ; 8(1) : 225
Abstract
Jamuar SS, Kuan JL, Brett M, Tiang Z, Tan WL, Lim JY, Liew WK, Javed A, Liew WK, Law HY, Tan ES, Lai A, Ng I, Teo YY, Venkatesh B, Reversade B, Tan EC, Foo R "Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?" EBioMedicine 2016 Mar ; 5 : 211-6
Abstract
Ackers-Johnson M, Li PY, Holmes AP, O\'Brien SM, Pavlovic D, Foo RS "A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart." Circ Res 2016 Sep 30 ; 119(8) : 909-20
Abstract
Rachmin I, Amsalem E, Golomb E, Beeri R, Gilon D, Fang P, Nechushtan H, Kay G, Guo M, Yiqing PL, Foo RS, Fisher DE, Razin E, Tshori S "FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy." Int J Cardiol 2015 Sep 15 ; 195 : 85-94
Abstract
Pilbrow AP, Cordeddu L, Cameron VA, Frampton CM, Troughton RW, Doughty RN, Whalle y GA, Ellis CJ, Yandle TG, Richards AM, Foo RS "Circulating miR-323-3p and miR-652: candidate markers for the presence and progression of acute coronary syndromes." Int J Cardiol 2014 Sep 20 ; 176(2) : 375-85
Abstract
Rachmin I, Tshori S, Smith Y, Oppenheim A, Marchetto S, Kay G, Foo RS, Dagan N, Golomb E, Gilon D, Borg JP, Razin E "Erbin is a negative modulator of cardiac hypertrophy." Proc Natl Acad Sci U S A 2014 Apr 22 ; 111(16) : 5902-7
Abstract
Siggens L, Figg N, Bennett M, Foo R "Nutrient deprivation regulates DNA damage repair in cardiomyocytes via loss of the base-excision repair enzyme OGG1." FASEB J 2012 May ; 26(5) : 2117-24 Epub 2012 Feb 1
Abstract
Gaspar-Pereira S, Fullard N, Townsend PA, Banks PS, Ellis EL, Fox C, Maxwell AG, Murphy LB, Kirk A, Bauer R, Caamaño JH, Figg N, Foo RS, Mann J, Mann DA, Oakley F "The NF-κB subunit c-Rel stimulates cardiac hypertrophy and fibrosis." Am J Pathol 2012 Mar ; 180(3) : 929-39 Epub 2011 Dec 30
Abstract
Haider S, Cordeddu L, Robinson E, Movassagh M, Siggens L, Vujic A, Choy MK, Goddard M, Lio P, Foo R "The landscape of DNA repeat elements in human heart failure." Genome Biol 2012 Oct 3 ; 13(10) : R90 Epub 2012 Oct 3
Abstract
Movassagh M, Vujic A, Foo R "Genome-wide DNA methylation in human heart failure." Epigenomics 2011 Feb ; 3(1) : 103-9
Abstract
Movassagh M, Choy MK, Knowles DA, Cordeddu L, Haider S, Down T, Siggens L, Vujic A, Simeoni I, Penkett C, Goddard M, Lio P, Bennett MR, Foo RS "Distinct epigenomic features in end-stage failing human hearts." Circulation 2011 Nov 29 ; 124(22) : 2411-22 Epub 2011 Oct 24
Abstract
Choy M, Movassagh M, Foo R "The human variome: genomic and epigenomic diversity." EMBO Mol Med 2011 Oct ; 3(10) : 573-4 Epub 2011 Aug 3
Abstract
Choy MK, Movassagh M, Goh HG, Bennett MR, Down TA, Foo RS "Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated." BMC Genomics 2010 ; 11 : 519 Epub 2010 Sep 27
Abstract
Choy MK, Movassagh M, Siggens L, Vujic A, Goddard M, Sánchez A, Perkins N, Figg N, Bennett M, Carroll J, Foo R "High-throughput sequencing identifies STAT3 as the DNA-associated factor for p53-NF-kappaB-complex-dependent gene expression in human heart failure." Genome Med 2010 ; 2(6) : 37 Epub 2010 Jun 14
Abstract
Movassagh M, Choy MK, Goddard M, Ben nett MR, Down TA, Foo RS "Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure." PLoS One 2010 ; 5(1) : e8564 Epub 2010 Jan 13
Abstract
Choy MK, Movassagh M, Bennett MR, Foo RS "PKB/Akt activation inhibits p53-mediated HIF1A degradation that is independent of MDM2." J Cell Physiol 2010 Mar ; 222(3) : 635-9
Abstract
Harzheim D, Talasila A, Movassagh M, Foo RS, Figg N, Bootman MD, Roderick HL "Elevated InsP3R expression underlies enhanced calcium fluxes and spontaneous extra-systolic calcium release events in hypertrophic cardiac myocytes." Channels (Austin) 2010 Jan-Feb ; 4(1) : 67-71 Epub 2010 Jan 17
Abstract
Harzheim D, Movassagh M, Foo RS, Ritter O, Tashfeen A, Conway SJ, Bootman MD, Roderick HL "Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+ transients and arrhythmias associated with cardiac hypertrophy." Proc Natl Acad Sci U S A 2009 Jul 7 ; 106(27) : 11406-11 Epub 2009 Jun 23
Abstract
Movassagh M, Foo RS "Simplified apoptotic cascades." Heart Fail Rev 2008 Jun ; 13(2) : 111-9
Abstract
Foo RS, Nam YJ, Ostreicher MJ, Metzl MD, Whelan RS, Peng CF, Ashton AW, Fu W, Mani K, Chin SF, Provenzano E, Ellis I, Figg N, Pinder S, Bennett MR, Caldas C, Kitsis RN "Regulation of p53 tetramerization and nuclear export by ARC." Proc Natl Acad Sci U S A 2007 Dec 26 ; 104(52) : 20826-31 Epub 2007 Dec 17
Abstract
Foo RS, Chan LK, Kitsis RN, Bennett MR "Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2." J Biol Chem 2007 Feb 23 ; 282(8) : 5529-35 Epub 2006 Dec 2
Abstract
Nam YJ, Mani K, Wu L, Peng CF, Calvert JW, Foo RS, Krishnamurthy B, Miao W, Ashton AW, Lefer DJ, Kitsis RN "The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant." J Biol Chem 2007 Feb 23 ; 282(8) : 5522-8 Epub 2006 Dec 1
Abstract
Foo RS, Siow RC, Brown MJ, Bennett MR "Heme oxygenase-1 gene transfer inhibits angiotensin II-mediated rat cardiac myocyte apoptosis but not hypertrophy." J Cell Physiol 2006 Oct ; 209(1) : 1-7
Abstract
Foo RS, Mani K, Kitsis RN "Death begets failure in the heart." J Clin Invest 2005 Mar ; 115(3) : 565-71
Abstract
A*STAR celebrates International Women's Day
From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders.
Get inspired by our #WomeninSTEM